MaxLinear Future Growth

Future criteria checks 4/6

MaxLinear is forecast to grow earnings and revenue by 90.1% and 16.2% per annum respectively. EPS is expected to grow by 90.9% per annum. Return on equity is forecast to be 10.1% in 3 years.

Key information

90.1%

Earnings growth rate

90.9%

EPS growth rate

Semiconductor earnings growth26.9%
Revenue growth rate16.2%
Future return on equity10.1%
Analyst coverage

Good

Last updated06 Jan 2025

Recent future growth updates

Recent updates

MaxLinear Heading For An Upturn, But The Valuation Seems To Anticipate This

Jan 10

Does MaxLinear (NASDAQ:MXL) Have A Healthy Balance Sheet?

Jan 02
Does MaxLinear (NASDAQ:MXL) Have A Healthy Balance Sheet?

MaxLinear, Inc.'s (NASDAQ:MXL) 40% Share Price Surge Not Quite Adding Up

Dec 06
MaxLinear, Inc.'s (NASDAQ:MXL) 40% Share Price Surge Not Quite Adding Up

Improved Revenues Required Before MaxLinear, Inc. (NASDAQ:MXL) Stock's 28% Jump Looks Justified

Sep 14
Improved Revenues Required Before MaxLinear, Inc. (NASDAQ:MXL) Stock's 28% Jump Looks Justified

MaxLinear: Why It Is In A Crapshoot At This Time

Sep 05

The Market Doesn't Like What It Sees From MaxLinear, Inc.'s (NASDAQ:MXL) Revenues Yet As Shares Tumble 32%

Jul 30
The Market Doesn't Like What It Sees From MaxLinear, Inc.'s (NASDAQ:MXL) Revenues Yet As Shares Tumble 32%

MaxLinear, Inc. (NASDAQ:MXL) Analysts Just Slashed This Year's Revenue Estimates By 15%

Jul 27
MaxLinear, Inc. (NASDAQ:MXL) Analysts Just Slashed This Year's Revenue Estimates By 15%

MaxLinear Is Beaten Down For A Reason, But Still Worth Watching

Jun 18

Does MaxLinear (NASDAQ:MXL) Have A Healthy Balance Sheet?

May 22
Does MaxLinear (NASDAQ:MXL) Have A Healthy Balance Sheet?

When Should You Buy MaxLinear, Inc. (NASDAQ:MXL)?

Mar 19
When Should You Buy MaxLinear, Inc. (NASDAQ:MXL)?

Are Investors Undervaluing MaxLinear, Inc. (NASDAQ:MXL) By 34%?

Mar 01
Are Investors Undervaluing MaxLinear, Inc. (NASDAQ:MXL) By 34%?

MaxLinear: The Slide May Not Yet Be Over

Jan 25

MaxLinear: Reality Has Set In For Its Valuation

Jan 17

MaxLinear, Inc. (NASDAQ:MXL) Held Back By Insufficient Growth Even After Shares Climb 31%

Dec 22
MaxLinear, Inc. (NASDAQ:MXL) Held Back By Insufficient Growth Even After Shares Climb 31%

Is Now The Time To Look At Buying MaxLinear, Inc. (NASDAQ:MXL)?

Dec 04
Is Now The Time To Look At Buying MaxLinear, Inc. (NASDAQ:MXL)?

A Look At The Fair Value Of MaxLinear, Inc. (NASDAQ:MXL)

Nov 16
A Look At The Fair Value Of MaxLinear, Inc. (NASDAQ:MXL)

Time To Worry? Analysts Are Downgrading Their MaxLinear, Inc. (NASDAQ:MXL) Outlook

Oct 27
Time To Worry? Analysts Are Downgrading Their MaxLinear, Inc. (NASDAQ:MXL) Outlook

Is MaxLinear (NASDAQ:MXL) Using Too Much Debt?

Sep 19
Is MaxLinear (NASDAQ:MXL) Using Too Much Debt?

What Is MaxLinear, Inc.'s (NASDAQ:MXL) Share Price Doing?

Sep 01
What Is MaxLinear, Inc.'s (NASDAQ:MXL) Share Price Doing?

MaxLinear, Inc. (NASDAQ:MXL) Analysts Are Reducing Their Forecasts For This Year

Jul 29
MaxLinear, Inc. (NASDAQ:MXL) Analysts Are Reducing Their Forecasts For This Year

Estimating The Fair Value Of MaxLinear, Inc. (NASDAQ:MXL)

Jul 10
Estimating The Fair Value Of MaxLinear, Inc. (NASDAQ:MXL)

We Ran A Stock Scan For Earnings Growth And MaxLinear (NASDAQ:MXL) Passed With Ease

Jun 26
We Ran A Stock Scan For Earnings Growth And MaxLinear (NASDAQ:MXL) Passed With Ease

Is MaxLinear (NASDAQ:MXL) A Risky Investment?

Jun 12
Is MaxLinear (NASDAQ:MXL) A Risky Investment?

At US$29.72, Is MaxLinear, Inc. (NASDAQ:MXL) Worth Looking At Closely?

May 30
At US$29.72, Is MaxLinear, Inc. (NASDAQ:MXL) Worth Looking At Closely?

A Look At The Intrinsic Value Of MaxLinear, Inc. (NASDAQ:MXL)

Apr 04
A Look At The Intrinsic Value Of MaxLinear, Inc. (NASDAQ:MXL)

MaxLinear, Inc. (NASDAQ:MXL) Investors Are Less Pessimistic Than Expected

Mar 22
MaxLinear, Inc. (NASDAQ:MXL) Investors Are Less Pessimistic Than Expected

If EPS Growth Is Important To You, MaxLinear (NASDAQ:MXL) Presents An Opportunity

Mar 09
If EPS Growth Is Important To You, MaxLinear (NASDAQ:MXL) Presents An Opportunity

When Should You Buy MaxLinear, Inc. (NASDAQ:MXL)?

Feb 23
When Should You Buy MaxLinear, Inc. (NASDAQ:MXL)?

Earnings and Revenue Growth Forecasts

NasdaqGS:MXL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202760981501862
12/31/2026558-3911127
12/31/2025445-76134111
12/31/2024358-224-60-4011
9/30/2024394-226-56-34N/A
6/30/2024448-190-35-16N/A
3/31/2024540-155-517N/A
12/31/2023693-732443N/A
9/30/2023858-494129N/A
6/30/20231,00965156204N/A
3/31/20231,105101248297N/A
12/31/20221,120125336389N/A
9/30/20221,078122287335N/A
6/30/20221,022103309358N/A
3/31/202294772213262N/A
12/31/202189242121168N/A
9/30/2021839-11188226N/A
6/30/2021766-5797126N/A
3/31/2021626-7986107N/A
12/31/2020479-995874N/A
9/30/2020354-821427N/A
6/30/2020277-505766N/A
3/31/2020295-316369N/A
12/31/2019317-207178N/A
9/30/2019335-116974N/A
6/30/2019340-217883N/A
3/31/2019359-3399107N/A
12/31/2018385-2695103N/A
9/30/2018411-4691100N/A
6/30/2018440-41N/A107N/A
3/31/2018442-16N/A64N/A
12/31/2017420-9N/A75N/A
9/30/201739419N/A81N/A
6/30/201737637N/A62N/A
3/31/201737449N/A101N/A
12/31/201638861N/A117N/A
9/30/201640044N/A114N/A
6/30/201639936N/A118N/A
3/31/2016368-17N/A90N/A
12/31/2015300-42N/A55N/A
9/30/2015234-36N/A25N/A
6/30/2015171-41N/A9N/A
3/31/2015136-11N/A12N/A
12/31/2014133-7N/A12N/A
9/30/2014132-7N/A21N/A
6/30/2014131-9N/A18N/A
3/31/2014126-11N/A16N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MXL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: MXL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MXL is expected to become profitable in the next 3 years.

Revenue vs Market: MXL's revenue (16.2% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: MXL's revenue (16.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MXL's Return on Equity is forecast to be low in 3 years time (10.1%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 06:41
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MaxLinear, Inc. is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David WilliamsBenchmark Company
Gary MobleyBenchmark Company
Jerome RamelBNP Paribas Exane